Radiosynthesis of [123I]N-methyl-4-iododexetimide and [123I]N-methyl-4-iodolevetimide: In vitro and in vivo characterisation of binding to muscarinic receptors in the rat heart
dc.contributor.author | Kassiou, M | en_AU |
dc.contributor.author | Mardon, K | en_AU |
dc.contributor.author | Katsifis, AG | en_AU |
dc.contributor.author | Najdovski, L | en_AU |
dc.contributor.author | Dikic, B | en_AU |
dc.contributor.author | Mattner, F | en_AU |
dc.contributor.author | Lambrecht, RM | en_AU |
dc.contributor.author | Hicks, RJ | en_AU |
dc.contributor.author | Eu,P | en_AU |
dc.contributor.author | Loc'h, C | en_AU |
dc.date.accessioned | 2025-08-08T04:40:39Z | en_AU |
dc.date.available | 2025-08-08T04:40:39Z | en_AU |
dc.date.issued | 1996-02 | en_AU |
dc.date.statistics | 2025-08-08 | en_AU |
dc.description.abstract | [123I]N-methyl-4-iododexetimide, [123I]MIDEX, and its pharmacologically inactive enantiomer [123I]N-methyl-4-iodolevetimide, [123I]MILEV were prepared via electrophilic iododesilylation using Chloramine-T as oxidising agent followed by N-methylation using methyl iodide. The radiotracers were purified with semi-preparative HPLC with radiochemical yields of 80 ± 11% (n = 6). The average time of synthesis was 100 min with specific activity >2000 Ci/mmol. In vitro, the binding of [123I]MIDEX, after addition of carrier, measured on homogenates of rat atrium was Bmax = 4.5 ± 0.4 pmol/mg protein, Kd = 3.3 ± 0.2 nM while in the ventricle Bmax = 2.3 ± 0.2 pmol/mg protein, Kd = 4.0 ± 1.4 nM. In vitro, the binding of [123I]MILEV was non-specific. The in vivo biodistribution of [123I]MIDEX showed high uptake in the atrium (3.2% ID/g) and left and right ventricles (2.2, 2.5% ID/g respectively) at 5 min followed by clearance. High heart-to-lung and moderate liver-to-lung ratios were obtained during 60 min. Radioactivity in the atrium and ventricles was reduced by pre-administration of the m-AChR antagonist MQNB (1 mg/kg). Pretreatment of rats with other m-AChR ligands, pirenzapine (M1), methoctramine (M2) and 4-DAMP (M3) also resulted in reduction of [123I]MIDEX uptake with methoctramine being the most potent. [123I]MIDEX distribution in the rat heart was not significantly inhibited by pre-administration of selective adrenergic drugs. The uptake was highly stereoselective since the inactive enantiomer, [123I]MILEV, demonstrated very low myocardial retention. The stability of [123I]MIDEX was evaluated by performing a metabolite study on atrium samples which revealed unchanged radiotracer 60 min postinjection. These results suggest that [123I]MIDEX may be a useful single photon agent for in vivo imaging of myocardial m-AChR in humans with [123I]MILEV offering the potential of assessing non-specific binding of the active tracer. © 1996 Published by Elsevier Inc. | en_AU |
dc.identifier.citation | Kassiou, M., Mardon, K., Katsifis, A. G., Najdovski, L., Dikic, B., Mattner, F., Lambrecht, R. M., Hicks, R. J., Eu, P., & Loc'h, C. (1996). Radiosynthesis of [123I]N-methyl-4-iododexetimide and [123I]N-methyl-4-iodolevetimide: In vitro and in vivo characterisation of binding to muscarinic receptors in the rat heart. Nuclear Medicine and Biology, 23(2), 147-153. doi:10.1016/0969-8051(95)02045-4 | en_AU |
dc.identifier.doi | 10.1016/0969-8051(95)02045-4 | en_AU |
dc.identifier.issn | 0969-8051 | en_AU |
dc.identifier.issue | 2 | en_AU |
dc.identifier.journaltitle | Nuclear Medicine and Biology | en_AU |
dc.identifier.pagination | 147-153 | en_AU |
dc.identifier.uri | https://apo.ansto.gov.au/handle/10238/16395 | en_AU |
dc.identifier.volume | 23 | en_AU |
dc.language.iso | en | en_AU |
dc.publisher | Elsevier | en_AU |
dc.relation.ispartof | Nuclear Medicine and Biology | en_AU |
dc.subject | Receptors | en_AU |
dc.subject | Genes | en_AU |
dc.subject | Chloramines | en_AU |
dc.subject | Rats | en_AU |
dc.subject | Rodents | en_AU |
dc.subject | In vivo | en_AU |
dc.subject | Heart | en_AU |
dc.subject | Lungs | en_AU |
dc.subject | Liver | en_AU |
dc.subject | Drugs | en_AU |
dc.subject | Tracer techniques | en_AU |
dc.title | Radiosynthesis of [123I]N-methyl-4-iododexetimide and [123I]N-methyl-4-iodolevetimide: In vitro and in vivo characterisation of binding to muscarinic receptors in the rat heart | en_AU |
dc.type | Journal Article | en_AU |
oaire.citation.issue | 2 | en_AU |
oaire.citation.volume | 23 | en_AU |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.63 KB
- Format:
- Item-specific license agreed upon to submission
- Description: